reference/4421726

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4421726

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1486
issn	1524-4628 0039-2499
issueIdentifier	5
pageRange	1482-1486
publicationName	Stroke
startingPage	1482
bibliographicCitation	Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke. 2008 May;39(5):1482–6. doi: 10.1161/strokeaha.107.500199. PMID: 18323500.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90e82a5ee0f54eaf101af7d0c0184189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a25cc9fe6aa68b1798392a7527fe5bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99e26195922be971b9286c02f02416fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dacc5b7b431ed648bf7ed5359b1f5e2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e7c40ab72aee40c6213ba3ec0b96e39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ab6568c6a515be298b4b62cae712bde http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4776-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33fde1784026839eec8c33b752b907f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf365e4ba685f12df64c487559057d36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa080f84ed76b79fe423ee53eea641a
date	200805
identifier	https://doi.org/10.1161/strokeaha.107.500199 https://pubmed.ncbi.nlm.nih.gov/18323500
isPartOf	https://portal.issn.org/resource/ISSN/1524-4628 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7613 https://portal.issn.org/resource/ISSN/0039-2499
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)
discusses	http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0002570 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0022871 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0216909 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0456879
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002543Q000139 http://id.nlm.nih.gov/mesh/D001281Q000150 http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D020521Q000188 http://id.nlm.nih.gov/mesh/D020521Q000209 http://id.nlm.nih.gov/mesh/D000925Q000008 http://id.nlm.nih.gov/mesh/D047228Q000008 http://id.nlm.nih.gov/mesh/D010975Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D001241Q000009 http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013988Q000031 http://id.nlm.nih.gov/mesh/D002543Q000517 http://id.nlm.nih.gov/mesh/D002543Q000503 http://id.nlm.nih.gov/mesh/D000077144 http://id.nlm.nih.gov/mesh/D000925Q000009 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D047228Q000009 http://id.nlm.nih.gov/mesh/D002985 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D000077405 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001713Q000008 http://id.nlm.nih.gov/mesh/D001713Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013988Q000008 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D013777Q000009 http://id.nlm.nih.gov/mesh/D013777Q000008 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D014859Q000009 http://id.nlm.nih.gov/mesh/D014859Q000008 http://id.nlm.nih.gov/mesh/D013988Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3749

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129957312 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129826180 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298

Total number of triples: 90.